← Leaderboards
Qian Chen
Rhode Island Hospital
$25,602,425
Attributed
$25,602,425
Total exposure
20
Grants
18
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.3M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$44,050,747 · 22
By mechanism
P20$27,202,404 · 12
P30$8,528,385 · 2
R01$6,003,281 · 3
R61$1,180,767 · 1
R33$396,670 · 1
R41$325,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “United States National Institutes Of Health”
- Leonard Freedman · Leidos Biomedical Research, Inc.$816,847,401
- Sonia M Thomas · Research Triangle Institute$701,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$642,073,624
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$513,687,120
- Tracy L Nolen · Research Triangle Institute$474,487,152
Research focus
United States National Institutes Of HealthMolecularCartilageFundingResearch PersonnelGrantCenters Of Research ExcellenceCellsProgramsDegenerative PolyarthritisChondrocytesJointsSkeletalMentorsMolecular BiologyTissuesCollaborationsResourcesEngineeringMultidisciplinaryRepairedEnvironmentDisciplineLaboratories
Grant awards (63)
Cell Senescence Regulating Osteoarthritis Progression: Sex-dependent Mechanisms$598,090
R01 · FY2025 · AG · contact PI
Cell Senescence Regulating Osteoarthritis Progression: Sex-dependent Mechanisms$615,231
R01 · FY2024 · AG · contact PI
Single-Cell Transposon Activation in the CNS during AD Progression: Sex-dependent Mechanisms$410,000
R01 · FY2024 · AG · contact PI
Cell Senescence Regulating Osteoarthritis Progression: Sex-dependent Mechanisms$621,363
R01 · FY2023 · AG · contact PI
COBRE for Skeletal Health & Repair$1,142,700
P30 · FY2021 · GM · contact PI
Core A: Administrative Core$475,243
P30 · FY2021 · GM · contact PI
Repressing Retrotransposon LINE-1: New Concepts for Osteoarthritis Treatment$396,670
R33 · FY2021 · AR · contact PI
COBRE for Skeletal Health & Repair$202,428
P30 · FY2021 · GM · contact PI
Core A: Administrative Core$201,416
P30 · FY2021 · GM · contact PI
COBRE for Skeletal Health & Repair$201,416
P30 · FY2021 · GM · contact PI
COBRE for Skeletal Health & Repair$1,145,969
P30 · FY2020 · GM · contact PI
Determining the Role of Retrotransposon LINE-1 in Alzheimers Disease$402,500
R61 · FY2020 · AR · contact PI
Repressing Retrotransposon LINE-1: New Concepts for Osteoarthritis Treatment$384,477
R61 · FY2020 · AR · contact PI
Developing Nanopieces, a Platform RNAi Delivery Technology for Treatment of Multiple Diseases$325,000
R41 · FY2020 · TR · contact PI
Core A: Administrative Core$323,421
P30 · FY2020 · GM · contact PI
COBRE for Skeletal Health & Repair$1,149,113
P30 · FY2019 · GM · contact PI
Developing novel Alzheimer's disease RNA therapeutics crossing the blood-brain barrier$393,791
P30 · FY2019 · GM · contact PI
Repressing Retrotransposon LINE-1: New Concepts for Osteoarthritis Treatment$393,790
R61 · FY2019 · AR · contact PI
Core A: Administrative Core$323,422
P30 · FY2019 · GM · contact PI
COBRE for Skeletal Health & Repair$1,152,137
P30 · FY2018 · GM · contact PI
Core A: Administrative Core$323,422
P30 · FY2018 · GM · contact PI
COBRE for Skeletal Health & Repair$1,170,485
P30 · FY2017 · GM · contact PI
Core A: Administrative Core$323,422
P30 · FY2017 · GM · contact PI
COBRE for Skeletal Health and Repair$2,095,645
P20 · FY2016 · GM · contact PI
COBRE for Skeletal Health and Repair$2,124,411
P20 · FY2015 · GM · contact PI
COBRE for Skeletal Health and Repair$2,184,581
P20 · FY2014 · GM · contact PI
COBRE for Skeletal Health and Repair$2,159,944
P20 · FY2013 · GM · contact PI
COBRE for Skeletal Health and Repair$2,192,326
P20 · FY2012 · GM · contact PI
COBRE for Skeletal Health and Repair$2,069,837
P20 · FY2011 · RR · contact PI
RI COBRE: ADMINISTRATIVE CORE$577,689
P20 · FY2011 · RR · contact PI
RI COBRE: IMAGING & MOLECULAR BIOLOGY$371,101
P20 · FY2011 · RR · contact PI
COBRE for Skeletal Health and Repair$2,090,744
P20 · FY2010 · RR · contact PI
RI COBRE: ADMINISTRATIVE CORE$377,316
P20 · FY2010 · RR · contact PI
RI COBRE: IMAGING & MOLECULAR BIOLOGY$319,089
P20 · FY2010 · RR · contact PI
Biophysical Regulation of Chondrocyte Differentiation$260,717
R01 · FY2010 · AG · contact PI
COBRE for Skeletal Health and Repair$2,081,367
P20 · FY2009 · RR · contact PI
COBRE for Skeletal Health and Repair$966,823
P20 · FY2009 · RR · contact PI
RI COBRE: ADMINISTRATIVE CORE$784,008
P20 · FY2009 · RR · contact PI
Biophysical Regulation of Chondrocyte Differentiation$263,351
R01 · FY2009 · AG · contact PI
RI COBRE: IMAGING & MOLECULAR BIOLOGY$225,370
P20 · FY2009 · RR · contact PI
COBRE for Skeletal Health and Repair$2,062,495
P20 · FY2008 · RR · contact PI
RI COBRE: ADMINISTRATIVE CORE$825,328
P20 · FY2008 · RR · contact PI
Stabilization of Matrix Structure in Mature Cartilage$321,974
R01 · FY2008 · AG · contact PI
Biophysical Regulation of Chondrocyte Differentiation$263,351
R01 · FY2008 · AG · contact PI
RI COBRE: IMAGING & MOLECULAR BIOLOGY$237,228
P20 · FY2008 · RR · contact PI
COBRE for Skeletal Health and Repair$2,619,017
P20 · FY2007 · RR · contact PI
RI COBRE: ADMINISTRATIVE CORE$602,373
P20 · FY2007 · RR · contact PI
Stabilization of Matrix Structure in Mature Cartilage$328,545
R01 · FY2007 · AG · contact PI
Biophysical Regulation of Chondrocyte Differentiation$268,725
R01 · FY2007 · AG · contact PI
RI COBRE: IMAGING & MOLECULAR BIOLOGY$235,712
P20 · FY2007 · RR · contact PI
Stabilization of Matrix Structure in Mature Cartilage$338,358
R01 · FY2006 · AG · contact PI
Biophysical Regulation of Chondrocyte Differentiation$276,750
R01 · FY2006 · AG · contact PI
Stabilization of Matrix Structure in Mature Cartilage$346,500
R01 · FY2005 · AG
Stabilization of Matrix Structure in Mature Cartilage$346,500
R01 · FY2004 · AG
BIOPHYSICAL REGULATION OF CHONDROCYTE DIFFERENTIATION$218,885
R01 · FY2002 · AG
STABILIZATION OF MATRIX STRUCTURE IN MATURE CARTILAGE$103,167
K02 · FY2002 · AG
BIOPHYSICAL REGULATION OF CHONDROCYTE DIFFERENTIATION$202,601
R01 · FY2001 · AG
STABILIZATION OF MATRIX STRUCTURE IN MATURE CARTILAGE$104,116
K02 · FY2001 · AG
STABILIZATION OF MATRIX STRUCTURE IN MATURE CARTILAGE$43,205
R29 · FY2001 · AG
BIOPHYSICAL REGULATION OF CHONDROCYTE DIFFERENTIATION$196,702
R01 · FY2000 · AG
BIOPHYSICAL REGULATION OF CHONDROCYTE DIFFERENTIATION$125,638
R01 · FY2000 · AG
STABILIZATION OF MATRIX STRUCTURE IN MATURE CARTILAGE$87,916
K02 · FY2000 · AG
STABILIZATION OF MATRIX STRUCTURE IN MATURE CARTILAGE$75,836
R29 · FY2000 · AG